about
Efficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week studyDual therapy strategies for COPD: the scientific rationale for LAMA + LABATen years of tiotropium: clinical impact and patient perspectivesMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseInhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment ParadigmSevere COPD Exacerbation Risk and Long-Acting Bronchodilator Treatments: Comparison of Three Observational Data Analysis Methods.Extrafine beclomethasone/formoterol compared to fluticasone/salmeterol combination therapy in COPDEfficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled trial.Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhalerPulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.Medical care of hepatitis B among Asian American populations: perspectives from three provider groups.Pneumocafé project: an inquiry on current COPD diagnosis and management among General Practitioners in Italy through a novel tool for professional education.Is it possible to diagnose the therapeutic adherence of patients with COPD in clinical practice? A cohort study.Ambulatory oxygen: why do COPD patients not use their portable systems as prescribed? A qualitative study.Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary diseaseWorking with the noncompliant patient.Bronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled dataComparison of the clinical features and outcomes in two age-groups of elderly patients with atrial fibrillation.Onset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasoneA telehealth program for self-management of COPD exacerbations and promotion of an active lifestyle: a pilot randomized controlled trial.Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study.Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysisThe combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects.Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study.Improving adherence with inhaler therapy in COPD.Ease-of-use, preference, confidence, and satisfaction with Revolizer(®), a novel dry powder inhaler, in an Indian populationA novel model-based approach for dose determination of glycopyrronium bromide in COPDImproving communication between the physician and the COPD patient: an evaluation of the utility of the COPD Assessment Test in primary care.Relationships between repeated instruction on inhalation therapy, medication adherence, and health status in chronic obstructive pulmonary disease.Indacaterol for chronic obstructive pulmonary disease: systematic review and meta-analysisQualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease.Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians.The role of galenic innovation in improving treatment compliance and persistence: three case studies.Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease.Communication of Pulmonary Function Test Results: A Survey of Patient's PreferencesConcerns about exercise are related to walk test results in pulmonary rehabilitation for patients with COPD.Comparative efficacy of indacaterol in chronic obstructive pulmonary disease.Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study.Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners.
P2860
Q21257191-E4EA51A5-D211-4F3E-A74F-8517028D86C8Q26752988-F880F88E-7AA9-45F2-98DC-48C339FA05A3Q26823682-4F315D81-8110-4F3F-B0F9-88B854892D45Q27000043-234136B6-FCCA-4F40-89D0-1B437879F40FQ28087788-0440553C-4D25-4055-B40D-967CEF692D4CQ31137121-780A2A41-C9D1-4C74-A9CD-334819B1EE13Q33558856-860C5CB1-819B-43B4-8F07-06D459D7F6BCQ33573085-70236EEA-78E5-4EC4-B79B-85E59A106478Q33693426-E22AF274-C679-4F64-92EE-D07FBD632745Q33711672-D2BA32CF-3CE8-40E8-8E2C-88DE7772CE2CQ33730890-67D25997-9C45-4724-A744-5DEDDB5E6720Q33770577-4174F07E-F31D-4FBA-B600-5B65C99AF414Q33801644-BAB1C6C6-5A30-43CF-A3A5-F2693CFA6A89Q33818711-126960B0-CEC7-40C1-838F-3CBF48612F17Q33895428-30D8A5B6-AB8D-410D-BFAD-C1ECB0DDE844Q34030818-C46039CB-8938-4015-9848-05F2BE446FEAQ34049219-F3CF2B75-2834-40CF-903C-5DF41FF2B2E8Q34062233-32516C8C-88B7-449B-81DC-0B38CF8181AFQ34128947-6B92F506-0972-424A-8E2C-B5180103EB97Q34198685-529ED012-86F2-4336-AD7F-D39EABD49674Q34273638-B39A2949-4CDA-4853-A7A7-D88F489D1541Q34316776-82037A13-D60A-4703-A404-1AD57F1D1204Q34368537-BE00105A-E6B1-46D7-8D4D-DE591D6861C8Q34423324-D384B836-A646-4DEB-A2DF-72E65BBCFE85Q34432533-1FE3F2E5-BA13-4BBB-B745-DFBD14876ED7Q34453118-C4ADA8D8-183E-41F6-9AA8-E4DF53586733Q34502782-39CA388C-9048-4E9C-AEDD-0D2EB5AAAEDDQ34511113-EDDE2D37-21B8-43E5-BA67-550890B44F50Q34621079-443D57AE-F498-4A55-8CBB-FE5BA655D928Q34962838-33F8558D-91C3-4727-864F-0456689BD80EQ35061912-982FBFD3-0391-4D2F-B9DC-39EF807F17F8Q35147196-EAD22659-8A92-487E-AA77-F9BA4A2C9A71Q35225129-2BBBF647-2493-45B0-BE03-4AD2C5C4E757Q35454381-D83E3845-C528-454D-89F9-F2653CF74BFBQ35508561-60320A23-B7ED-4552-B92F-9A2EF2E6F66CQ35581576-360C056F-5C34-4C2C-A950-330E00814077Q35751845-6C93018D-934F-4895-90AB-1E9E29A5DBECQ35822146-BD2434A3-28A3-4276-A998-EF9E09BD9013Q35892527-C2C6D5FE-1E01-4802-8C34-A557B85EE53EQ36024374-B93E03F8-C429-49B8-9782-66078A8AEEF4
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Patient adherence in COPD.
@ast
Patient adherence in COPD.
@en
type
label
Patient adherence in COPD.
@ast
Patient adherence in COPD.
@en
prefLabel
Patient adherence in COPD.
@ast
Patient adherence in COPD.
@en
P2860
P356
P1433
P1476
Patient adherence in COPD
@en
P2093
J Bourbeau
P2860
P304
P356
10.1136/THX.2007.086041
P407
P577
2008-09-01T00:00:00Z